January 18, 2017 | Thomson Reuters dug up investment numbers for all of the top 100 VCs investing in biotech, and Endpoints News ranked them. Flagship, Third Rock, New Enterprise Associates, and Arch Venture are the top four, and many of the top four players remain focused on early stage investment. ENDPOINTS NEWS